Search results
Aaron is a founder and Managing Partner of Scion. He has spent over a decade specializing in founding, building and investing in life sciences companies, focusing primarily on therapeutics.
View Aaron Kantoff’s profile on LinkedIn, a professional community of 1 billion members.
- 500+
- Biotech Investor & Venture Capitalist
- 4.6K
- Scion Life Sciences
Founder, Managing Partner Scion. Aaron is a founder and Managing Partner of Scion. He has spent over a decade specializing in founding, building and investing in life sciences companies, focusing primarily on therapeutics.
Jun 12, 2024 · Aaron Kantoff is a founder and Managing Partner of Scion Life Sciences, a New York City-based life sciences venture capital firm dedicated to founding and building exceptional biotechnology companies that discover, develop, and seek to commercialize clinically transformational or curative new medicines. Aaron currently serves as a board member ...
Feb 7, 2024 · Aaron M. Kantoff. Aaron is a founder and Managing Partner of Scion. He has spent over a decade specializing in founding, building, and investing in life sciences companies, focusing primarily on therapeutics. Aaron currently serves as a board member of Tourmaline Bio (NASDAQ: TRML), where he has been serving since the company’s inception.
Aaron Kantoff is the Principal at Apple Tree Partners. Additionally, Aaron Kantoff has had 1 past job as the Venture Partner at Medicxi.
Aaron is a co-founder of RayzeBio and currently serves as a Venture Partner in the Medicxi investment team. Prior to joining Medicxi, Aaron was a partner with Apple Tree Partners (ATP), where he was a key member of the life science investment team since 2011.
